ArticleClinical pharmacology and therapeutics2026
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data.
Francesco Pignatti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.